Gilead Sciences
$2.1B Assets Reported
6 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ACLX | Arcellx Inc | 6,720,803 | $772M | 36.4% |
| RCUS | Arcus Biosciences Inc | 31,424,760 | $679M | 32.1% |
| LKFT | Galapagos NV | 16,707,477 | $501M | 23.7% |
| ASMB | Assembly Biosciences Inc | 4,505,391 | $125M | 5.9% |
| KYTX | Kyverna Therapeutics Inc | 4,126,119 | $36M | 1.7% |
| XLO | Xilio Therapeutics Inc | 650,389 | $5M | 0.3% |
Track Gilead Sciences's 13F portfolio: $2.1B in reported holdings, 6 positions. Top holdings, AUM, and quarterly changes on SentiSense.